Last updated:
ID:
401206
Start date:
17 April 2025
Project status:
Current
Principal investigator:
Dr Trent Fowler
Lead institution:
Otsuka Pharmaceutical Development and Commercialization Inc., United States of America

The identification of features or “markers” from data collected from patients suffering from disorders of the central nervous system, such as Epilepsy and Depression, plays a key role in research studying these diseases. Such features may take many forms, such as: organ shape, protein composition in blood or urine, sleep patterns, and psychological distress. Using computational methods, these key features may be identified and applied to data from past and current research. These findings would ultimately result in expedited research using the identified biomarkers to analyze disease progression, abatement, and characteristic healthy features. This project is projected to last at least three years, with the public benefiting from this project through advancement of current and future research in pathologies detrimental to public health.